Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size

Journal of Pharmaceutical Sciences

Volumn 95, Issue 6, 2006, Pages 1382-1392

  Coates, Matthew S ^a,b   Chan, Hak Kim ^b   Fletcher, David F ^a   Raper, Judy A ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c Missouri University of Science and Technology   (United States)

Author keywords

Aerosols; Computational fluid dynamics, CFD; Computational modeling; Dry powder inhaler, DPI; Pulmonary; Pulmonary drug delivery; Targeted drug delivery

Indexed keywords

MANNITOL;

AEROSOL; ARTICLE; COMPUTATIONAL FLUID DYNAMICS; DISPERSION; DRUG DELIVERY SYSTEM; DRY POWDER; FLOW RATE; KINETICS; METHODOLOGY; POWDER INHALER; PREDICTION;

EID: 33745056503     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20603     Document Type: Article

References (21)

1. Zeng XM, Martin GP, Tee S-K, Marriott C. 1998. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. Int J Pharm 176:99-110.
2. French DL, Edwards DA, Niven RW. 1996. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J Aerosol Sci 27:769-783.
3. Chew NYK, Bagster D, Chan H-K, 2000. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int J Pharm 206:75-83.
4. Chew NYK, Chan H-K. 1999. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders. Pharm Res 16:1098-1103.
5. Steckel H, Müller BW. 1997. In vitro evaluation of dry powder inhalers I: Drug deposition of commonly used devices. Int J Pharm 154:19-29.
6. Coates MS, Fletcher DF, Chan H-K, Raper JA. 2004. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length. J Pharm Sci 93:2863-2876.
7. Coates MS, Chan H-K, Fletcher DF, Raper JA. 2005. Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses. Pharm Res 22:1445-1453.
8. Voss A, Finlay WH. 2002. Deagglomeration of dry powder pharmaceutical aerosols. Int J Pharm 248: 39-50.
9. Clark AR, Hollingworth A. 1993. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-Implications for In Vitro testing. J Aerosol Med 6:99-110.
10. De Boer AH, Winter HMI, Lerk CF. 1996. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 1: Inhalation characteristics, work of breathing, and volunteer's preference in dependence of the inhaler resistance. Int J Pharm 130:231-244.
11. De Boer AH, Gjaltema D, Hagedoorn P. 1996. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 2: Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int J Pharm 138:45-56.
12. De Boer AH, Bolhuis GK, Gjaltema D, Hagedoorn P. 1997. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 3: the effect of flow rate increase (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Int J Pharm 153:66-77.
13. Chavan V, Dalby R. 2002. Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler. AAPS Pharm Sci 4(2): Article 6.
14. ANSYS CFX. 2003. www.ansys.com/cfx (accessed 08/01/04).
15. Menter FR. 1994. Two-equation eddy viscosity models for engineering applications. AIAA J 32: 269-289.
16. Coates MS, Chan H-K, Fletcher DF, Raper JA. 2005. The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses. Pharm Res 22:923-932.
17. Stecher PG, Windholz M, Leahy DS, editors. 1968. The Merck Index: An encyclopedia of chemicals and drugs. 8th Edition, Rahway: Merck & Co., Inc., p 664.
18. Asking L, Olsson B. 1997. Calibration at different flow rates of a multistage liquid impinger. Aerosol Sci Tech 27:39-49.
19. Finlay WH. 2001. The mechanics of inhaled pharmaceutical aerosols. London: Academic Press Inc., Ltd.3
20. Chew NYK, Chan H-K, Bagster DF, Mukhraiya J. 2002. Characterization of pharmaceutical powder inhalers: estimation of energy input for powder dispersion and effect of capsule device configuration. J Aerosol Sci 33:999-1008.
21. Clark AR, Bailey R. 1996. Inspiratory flow profiles in disease and their effects on the delivery characteristics of dry powder inhalers. In: Dalby RN, Byron PR, Farr SJ, editors. Respiratory drug delivery V. Buffalo Grove, IL: Interpharm Press, pp 221-230.